相关实验视频
Updated: Jun 14, 2025

11:10
Isolation of Human Islets from Partially Pancreatectomized Patients
Published on: July 30, 2011
16.1K
卵巢癌与非岛屿细胞瘤低血糖的初始表现:一个病例报告
Shatha Elemian1, Samer Jumean1, Amy Paige2
1Department of Internal Medicine, Saint Michael's Medical Center, New York Medical College, Newark, USA.
Cureus
|September 2, 2024
概括
本案例研究详细介绍了一种罕见的卵巢癌肉瘤,呈现为非岛屿细胞瘤低血糖症 (NICTH). 低血糖症是由瘤过度产生胰岛素样生长因子-II (IGF-II) 引起的.
科学领域:
- 在瘤学瘤学.
- 内分泌学 在内分泌学.
- 病理学 病理学 病理学
背景情况:
- 卵巢癌是女性癌症死亡的重要原因之一.
- 麻性综合征,包括非岛屿细胞瘤低血糖症 (NICTH),可能与卵巢癌有关.
- NICTH的特点是瘤细胞过度产生胰岛素样生长因子II (IGF-II).
研究的目的:
- 报告一个罕见的卵巢癌肉瘤 (OCS) 病例,呈现NICTH.
- 为了突出诊断挑战和管理这种罕见的副瘤综合征.
- 为了强调识别卵巢癌罕见表现的重要性.
主要方法:
- 一个55岁妇女的病例报告,她患有腹部张张和严重的低血糖症.
- 实验室研究包括抑制的胰岛素/C和高的IGF-II/IGF1比率.
- 图像 (CT扫描) 和活检用于诊断转移性OCS和NICTH.
主要成果:
- 患者呈现了耐药性低血糖症和升高的IGF-II/IGF1比率 (>32).
- 转移性卵巢癌与腹膜癌症的诊断得到确认.
- 由于瘤IGF-II分泌而导致的低血糖.
结论:
- 这是第一个报告的转移性OCS病例,最初与NICTH.
- 像NICTH这样的罕见副瘤综合征需要全面的诊断和管理方法.
- 转移性OCS可能会出现复杂和不寻常的临床表现.
相关概念视频
Hypoglycemia and Glucagon
217
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
217
Diabetes Mellitus: Type 2 and Gestational
2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
1.2K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
Insulin and C-peptide are...
1.2K
Oral Hypoglycemic Agents: Biguanides and Glitazones
183
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
183
Diabetes: Symptoms, Diagnosis, and Complications
520
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
520

